tiprankstipranks
Trending News
More News >
Propanc Biopharma Inc (PPCBD)
:PPCBD
US Market
Advertisement

Propanc Biopharma (PPCBD) Income Statement

Compare
44 Followers

Propanc Biopharma Income Statement

Last quarter (Q2 2025), Propanc Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Propanc Biopharma's net income was $-430.18K. See Propanc Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -34.15K$ -28.84K$ -28.37K$ -28.11K$ -32.81K
Operating Expenses
$ 1.50M$ 1.78M$ 1.99M$ 1.81M$ 3.49M
Depreciation and Amortization
$ 0.00$ 22.93K---
EBITDA
$ -1.54M$ -1.78M$ -1.99M$ -1.81M$ -3.49M
Operating Income
$ -1.54M$ -1.78M$ -1.99M$ -1.81M$ -3.49M
Other Income/Expenses
$ -413.61K$ -1.01M$ -722.19K$ -327.22K$ -1.38M
Pretax Income
$ -1.95M$ -2.79M$ -2.71M$ -2.14M$ -4.88M
Net Income
$ -1.82M$ -3.13M$ -3.36M$ -2.42M$ -4.74M
Per Share Metrics
Basic EPS
$ -0.02$ -1.80$ -49.23$ -797.23$ -192.45K
Diluted EPS
$ -0.02$ -1.80$ -49.23$ -797.23$ -192.45K
Weighted Average Shares Outstanding
85.05M 1.74M 68.22K--
Weighted Average Shares Outstanding (Diluted)
85.05M 1.74M 68.22K--
Currency in USD

Propanc Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis